Searched for
SUN PHARMA BOND ISSUANCE
The one number every investor must track is the US 10-year yield: Anand Vardarajan09 Oct, 2026, 05.02 PM IST
Sun Life CEO Kevin Strain On The Opportunities in Asset Management Business26 Sep, 2026, 11.52 AM IST
Sun Life’s Kevin Strain on Why Bancassurance Partners Are Critical25 Sep, 2026, 12.48 PM IST
Sun Life’s Kevin Strain On Why it Wont Raise Stake in Aditya Birla Yet23 Sep, 2026, 12.37 PM IST
Sun Life’s Kevin Strain on How Regulating Insurance is a Two-Way Street24 Sep, 2026, 12.11 PM IST
Sun Life CEO Kevin Strain on Why will Aid, Not Replace Insurers23 Sep, 2026, 12.59 PM IST
Oil prices, US bond yields weigh on Dalal Street: 4 key reasons behind Sensex selloff24 Sep, 2026, 05.17 PM IST
Sun Life’s Kevin Strain on India Plans, FDI, Aditya-Birla, Bancassurance and AI21 Sep, 2026, 11.08 AM IST
Sun Life CEO Kevin Strain: Why Full Ownership Isn’t the Prize in India | ET WLF 202621 Sep, 2026, 07.00 AM IST
‘Trump remembers Modi stood by him’: Sergio Gor on India-US bond, trade deal & challenges22 Aug, 2026, 03.45 PM IST
Sun Pharma Q2 Results: Net profit jumps 8% YoY to Rs 2,260 cr; revenue up 14%01 Nov, 2022, 03.18 PM IST
Sun Pharma Q1 Results: PAT dips 2% YoY to Rs 2,023 cr on one-time expense03 Aug, 2023, 07.31 PM IST
Sun Pharma Q2 Results: PAT beats estimates, rises 6% YoY to Rs 2,385 cr; revenue up 11%01 Nov, 2023, 06.21 PM IST
Sun Pharma Q4 Results: India's largest drugmaker reports net profit of Rs 1,985 crore27 May, 2023, 03.43 PM IST
Stock Radar: Buy Sun Pharma for a target of Rs 918-935, recommends Ruchit Jain21 Sep, 2022, 12.15 PM IST
Watch: Sun Pharma posts cons loss of Rs 425 crore in June quarter11 Aug, 2017, 04.28 PM IST
Sun Pharma posts loss of Rs 2,277 cr in Q4 due to one-time exceptional loss of Rs 3,936 cr30 May, 2022, 04.32 PM IST